Dellora Investments Master Fund LP 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:09 am Sale | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments Master Fund LP | 0 0.000% | -43,250 (Position Closed) | Filing |
| 2023-02-13 4:16 pm Unchanged | 2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments Master Fund LP | 43,250 5.200% | 0 (Unchanged) | Filing |
| 2022-08-22 1:17 pm Purchase | 2022-08-11 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments Master Fund LP | 43,250 5.200% | 43,250 (New Position) | Filing |